LON:CLBX
Cellbxhealth PLC
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
1.37p
Buy <=wait / entry
0.90p
Trim >=take some off
1.30p
Thesis breakA confirmed Q1 2026 revenue miss below the deferred GBP 0.2m combined with a diluti...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 16% | 100 / 100 | 16.0 |
| Base case | 48% | 62 / 100 | 29.8 |
| Bear case | 36% | 10 / 100 | 3.6 |
| Weighted conviction | 49 / 100 - SPECULATIVE BUY | ||
Top risks
- FY2025 revenue of GBP 1.4m missed GBP 1.6m guidance after GBP 0.2m sales deferred to Q1 2026
- Biopharma revenue GBP 0.3m and product revenue GBP 1.1m showing minimal commercial traction
- Voluntary delisting from AIM as part of cost rationalisation